术前呼吸暂停严重程度增加可改善阻塞性睡眠呼吸暂停治疗中上气道刺激的应答
该回顾性队列研究纳入2015年8月至2016年12月在一家三级学术医疗中心接受上气道刺激治疗的连续25例CPAP难治性OSA患者,分析临床预测因素。结果显示AHI平均下降33.8次/小时,术前AHI越高应答越明显,83%患者术后AHI<5,92%患者AHI<10,作者认为更严重的术前AHI可能扩大适应证但需进一步研究。
要点
- 接受上气道刺激治疗的25例CPAP难治性OSA患者中,AHI平均下降33.8次/小时。
- 术前AHI每增加1点,治疗后AHI平均多下降1.03点。
- 83%的患者治疗后AHI<5,92%的患者AHI<10,平均设备使用49.5小时/周。
核心结论
- 上气道刺激治疗CPAP难治性OSA持续普及,识别治疗成功的预测因素至关重要。
- 该研究样本量虽小,但提示更严重的术前AHI并不妨碍显著的治療应答,并可能扩大上气道刺激的纳入标准,值得进一步研究。
- 证据等级为4级。
研究设计与样本
- 回顾性病历分析,纳入2015年8月至2016年12月在一家三级学术医疗中心接受上气道刺激治疗的最初25例连续患者。
- 收集人口学数据、内科与睡眠病史、术前和术后多导睡眠监测数据及睡眠内镜检查结果。
- 采用双侧t检验及双变量与线性回归分析进行统计分析。
主要发现
- 25例患者平均年龄67.5±7.6岁,平均体质指数28.2±3.8 kg/m2,女性占42%。
- 1例患者因治疗中完全中枢性呼吸暂停暴露而被排除分析。
- 治疗后AHI平均下降33.8次/小时(95%CI:25.8至41.7,P<0.001)。
- 术前AHI与治疗应答相关,术前AHI每增加1点,平均多下降1.03点(P<0.001)。
- 83%的患者治疗后AHI<5,92%的患者AHI<10;平均设备使用时间为49.5±10.4小时/周;92%的患者手术当日出院;无重大不良事件发生。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文称该研究样本量小(although small)。
- 原文结论提出值得进一步研究(meriting further investigation)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Examine the patient characteristics of those undergoing upper airway stimulation (UAS) for the treatment of continuous positive airway pressure (CPAP)-refractive obstructive sleep apnea (OSA) at a tertiary care medical center to determine objective clinical predictors of success. METHODS: Retrospective chart review of the first 25 consecutive patients between August 2015 and December 2016 treated with UAS at a tertiary care academic center. Demographic data, medical and sleep history, pre- and postoperative polysomnography data, and sleep endoscopy findings were collected. Statistical analysis was performed using two-sided t test with bivariate and linear regression analysis. RESULTS: In our cohort of 25 patients, mean age was 67.5 ± 7.6 years, and mean body mass index (BMI) was 28.2 ± 3.8 kg/m2 with 42% female. One patient was excluded from analysis for unmasking of complete central apnea with therapy. AHI decreased by a mean of 33.8 events/hour following treatment (95% confidence interval: 25.8 to 41.7, P < 0.001). Preintervention AHI was associated with therapy response, with each point of preintervention AHI leading to an average decrease of 1.03 points (P < 0.001). Eighty-three percent of patients achieved a treatment AHI < 5, whereas 92% achieved an AHI < 10. Mean device use was 49.5 ± 10.4 hours per week. Ninety-two percent of patients were discharged the day of surgery. No major adverse events occurred. CONCLUSION: UAS continues to gain popularity for the treatment of CPAP-refractive OSA; therefore, identification of predictors of success is crucial. Our study, although small, suggests that more severe preintervention AHI does not preclude significant therapy response and may expand the inclusion criteria for UAS, meriting further investigation. LEVEL OF EVIDENCE: 4 Laryngoscope, 130:556-560, 2020.
引用
- Evans SS, Richman J, Cho DY, et al. Increasing preoperative apnea severity improves upper airway stimulation response in OSA treatment. Laryngoscope. 2019. PMID: 31038747. doi:10.1002/lary.28009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。